1. Home
  2. OGEN vs OMH Comparison

OGEN vs OMH Comparison

Compare OGEN & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • OMH
  • Stock Information
  • Founded
  • OGEN 1996
  • OMH 2015
  • Country
  • OGEN United States
  • OMH Singapore
  • Employees
  • OGEN N/A
  • OMH N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • OGEN Health Care
  • OMH Finance
  • Exchange
  • OGEN Nasdaq
  • OMH Nasdaq
  • Market Cap
  • OGEN 4.6M
  • OMH 5.1M
  • IPO Year
  • OGEN N/A
  • OMH 2023
  • Fundamental
  • Price
  • OGEN $0.20
  • OMH $1.50
  • Analyst Decision
  • OGEN
  • OMH Strong Buy
  • Analyst Count
  • OGEN 0
  • OMH 1
  • Target Price
  • OGEN N/A
  • OMH $15.00
  • AVG Volume (30 Days)
  • OGEN 351.6K
  • OMH 4.5M
  • Earning Date
  • OGEN 05-09-2025
  • OMH 06-26-2025
  • Dividend Yield
  • OGEN N/A
  • OMH N/A
  • EPS Growth
  • OGEN N/A
  • OMH N/A
  • EPS
  • OGEN N/A
  • OMH N/A
  • Revenue
  • OGEN N/A
  • OMH $7,976,578.00
  • Revenue This Year
  • OGEN N/A
  • OMH $28.40
  • Revenue Next Year
  • OGEN N/A
  • OMH N/A
  • P/E Ratio
  • OGEN N/A
  • OMH N/A
  • Revenue Growth
  • OGEN N/A
  • OMH 117.53
  • 52 Week Low
  • OGEN $0.16
  • OMH $0.25
  • 52 Week High
  • OGEN $3.43
  • OMH $4.33
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 52.52
  • OMH 36.63
  • Support Level
  • OGEN $0.18
  • OMH $2.79
  • Resistance Level
  • OGEN $0.22
  • OMH $3.75
  • Average True Range (ATR)
  • OGEN 0.02
  • OMH 0.58
  • MACD
  • OGEN 0.00
  • OMH -0.17
  • Stochastic Oscillator
  • OGEN 66.67
  • OMH 1.05

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.

Share on Social Networks: